You are here

Association of Genetic Variation With Keratoconus.

TitleAssociation of Genetic Variation With Keratoconus.
Publication TypeJournal Article
Year of Publication2020
AuthorsMcComish, BJ, Sahebjada, S, Bykhovskaya, Y, Willoughby, CE, Richardson, AJ, Tenen, A, Charlesworth, JC, Macgregor, S, Mitchell, P, Lucas, SEM, Mills, RA, Mackey, DA, Li, X, Wang, JJin, Jensen, RA, Rotter, JI, Taylor, KD, Hewitt, AW, Rabinowitz, YS, Baird, PN, Craig, JE, Burdon, KP
JournalJAMA Ophthalmol
Volume138
Issue2
Pagination174-181
Date Published2020 02 01
ISSN2168-6173
KeywordsAdult, Female, Fuchs' Endothelial Dystrophy, Genetic Predisposition to Disease, Genome-Wide Association Study, Humans, Keratoconus, Lipase, Logistic Models, Male, Middle Aged, Polymorphism, Single Nucleotide
Abstract<p><b>Importance: </b>Keratoconus is a condition in which the cornea progressively thins and protrudes in a conical shape, severely affecting refraction and vision. It is a major indication for corneal transplant. To discover new genetic loci associated with keratoconus and better understand the causative mechanism of this disease, we performed a genome-wide association study on patients with keratoconus.</p><p><b>Objective: </b>To identify genetic susceptibility regions for keratoconus in the human genome.</p><p><b>Design, Setting, and Participants: </b>This study was conducted with data from eye clinics in Australia, the United States, and Northern Ireland. The discovery cohort of individuals with keratoconus and control participants from Australia was genotyped using the Illumina HumanCoreExome single-nucleotide polymorphism array. After quality control and data cleaning, genotypes were imputed against the 1000 Genomes Project reference panel (phase III; version 5), and association analyses were completed using PLINK version 1.90. Single-nucleotide polymorphisms with P < 1.00 × 10-6 were assessed for replication in 3 additional cohorts. Control participants were drawn from the cohorts of the Blue Mountains Eye Study and a previous study of glaucoma. Replication cohorts were from a previous keratoconus genome-wide association study data set from the United States, a cohort of affected and control participants from Australia and Northern Ireland, and a case-control cohort from Victoria, Australia. Data were collected from January 2006 to March 2019.</p><p><b>Main Outcomes and Measures: </b>Associations between keratoconus and 6 252 612 genetic variants were estimated using logistic regression after adjusting for ancestry using the first 3 principal components.</p><p><b>Results: </b>The discovery cohort included 522 affected individuals and 655 control participants, while the replication cohorts included 818 affected individuals (222 from the United States, 331 from Australia and Northern Ireland, and 265 from Victoria, Australia) and 3858 control participants (2927 from the United States, 229 from Australia and Northern Ireland, and 702 from Victoria, Australia). Two novel loci reached genome-wide significance (defined as P < 5.00 × 10-8), with a P value of 7.46 × 10-9 at rs61876744 in patatin-like phospholipase domain-containing 2 gene (PNPLA2) on chromosome 11 and a P value of 6.35 × 10-12 at rs138380, 2.2 kb upstream of casein kinase I isoform epsilon gene (CSNK1E) on chromosome 22. One additional locus was identified with a P value less than 1.00 × 10-6 in mastermind-like transcriptional coactivator 2 (MAML2) on chromosome 11 (P = 3.91 × 10-7). The novel locus in PNPLA2 reached genome-wide significance in an analysis of all 4 cohorts (P = 2.45 × 10-8).</p><p><b>Conclusions and Relevance: </b>In this relatively large keratoconus genome-wide association study, we identified a genome-wide significant locus for keratoconus in the region of PNPLA2 on chromosome 11.</p>
DOI10.1001/jamaophthalmol.2019.5293
Alternate JournalJAMA Ophthalmol
PubMed ID31855235
PubMed Central IDPMC6990728
Grant ListR01 EY009052 / EY / NEI NIH HHS / United States
HHSN268201200008I / HL / NHLBI NIH HHS / United States
UL1 TR001881 / TR / NCATS NIH HHS / United States
HHSN268201200036C / HL / NHLBI NIH HHS / United States
HHSN268200800007C / HL / NHLBI NIH HHS / United States
HHSN268201800001C / HL / NHLBI NIH HHS / United States
N01HC55222 / HL / NHLBI NIH HHS / United States
N01HC85079 / HL / NHLBI NIH HHS / United States
N01HC85080 / HL / NHLBI NIH HHS / United States
N01HC85081 / HL / NHLBI NIH HHS / United States
N01HC85082 / HL / NHLBI NIH HHS / United States
N01HC85083 / HL / NHLBI NIH HHS / United States
N01HC85086 / HL / NHLBI NIH HHS / United States
U01 HL080295 / HL / NHLBI NIH HHS / United States
U01 HL130114 / HL / NHLBI NIH HHS / United States
R01 AG023629 / AG / NIA NIH HHS / United States
ePub date: 
20/02